Differentiation of tumor sensitivity to photodynamic therapy and early evaluation of treatment effect by nuclear medicine techniques

Annals of Nuclear Medicine

Volumn 27, Issue 7, 2013, Pages 669-675

  Liu, Jie ^a   Ogawa, Mikako ^a   Sakai, Toshihiro ^a   Takashima, Misato ^a   Okazaki, Shigetoshi ^a   Magata, Yasuhiro ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

18F FDG; 99mTc MIBI; Photodynamic therapy (PDT)

Indexed keywords

CELL PROTEIN; FLUORODEOXYGLUCOSE F 18; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PHOTOFRIN; SINGLET OXYGEN; TRYPAN BLUE;

ARTICLE; CELL VIABILITY; CLINICAL EVALUATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; INCUBATION TIME; IRRADIATION; MALE; NEAR INFRARED SPECTROSCOPY; NITROBLUE TETRAZOLIUM TEST; PHOTODYNAMIC THERAPY; PREDICTION; PRIORITY JOURNAL; RADIATION ABSORPTION; SENSITIVITY ANALYSIS; TREATMENT RESPONSE; TUMOR CELL;

BIOLOGICAL TRANSPORT; CELL LINE, TUMOR; DIHEMATOPORPHYRIN ETHER; FLUORODEOXYGLUCOSE F18; HUMANS; NUCLEAR MEDICINE; PHOTOCHEMOTHERAPY; TECHNETIUM TC 99M SESTAMIBI; TIME FACTORS; TREATMENT OUTCOME;

EID: 84882708433     PISSN: 09147187     EISSN: 18646433     Source Type: Journal    
DOI: 10.1007/s12149-013-0734-4     Document Type: Article

References (32)

1. Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, Gollnick SO, et al. Photodynamic therapy of cancer: an update. CA Cancer J Clin. 2011;61:250-81.
2. Huang Z, Xu H, Meyers AD, Musani AI, Wang L, Tagg R, et al. Photodynamic therapy for treatment of solid tumors-potential and technical challenges. Technol Cancer Res Treat. 2008;7:309-20.
3. Zhao H, Xing D, Chen Q. New insights of mitochondria reactive oxygen species generation and cell apoptosis induced by low dose photodynamic therapy. Eur J Cancer. 2011;47:2750-61.
4. Wyld L, Reed MW, Brown NJ. Differential cell death response to photodynamic therapy is dependent on dose and cell type. Br J Cancer. 2001;84:1384-6.
5. Ke MS, Xue LY, Feyes DK, Azizuddin K, Baron ED, McCormick TS, et al. Apoptosis mechanisms related to the increased sensitivity of Jurkat T-cells vs A431 epidermoid cells to photodynamic therapy with the phthalocyanine Pc 4. Photochem Photobiol. 2008;84:407-14.
6. Adams K, Rainbow AJ, Wilson BC, Singh G. In vivo resistance to photofrin-mediated photodynamic therapy in radiation-induced fibrosarcoma cells resistant to in vitro Photofrinmediated photodynamic therapy. J. Photochem. Photobiol. B Biol. 1999;49:136-41.
7. Xie Y, Wei ZB, Zhang Z, Wen W, Huang GW. Effect of 5-ALA-PDT on VEGF and PCNA expression in human NPC-bearing nude mice. Oncol Rep. 2009;22:1365-71.
8. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646-74.
9. Zhu A, Lee D, Shim H. Metabolic positron emission tomography imaging in cancer detection and therapy response. Semin Oncol. 2011;38:55-69.
10. Gatenby RA, Gillies RJ. Glycolysis in cancer: a potential target for therapy. Int J Biochem Cell Biol. 2007;39:1358-66.
11. Arbab AS, Koizumi K, Toyama K, Araki T. Uptake of technetium-99m- tetrofosmin, technetium-99m-MIBI and thallium-201 in tumor cell lines. J Nucl Med. 1996;37:1551-6.
12. Fuchtner F, Steinbach J, Mading P, Johannsen B. Basic hydrolysis of 2-[18F] fluoro-1,3,4,6-tetra-O-acetyl-d-glucose in the preparation of 2-[18F] fluoro-2-deoxy-d-glucose. Appl Radiat Isot. 1996;47:61-6.
13. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-75.
14. Monner DA. An assay for growth of mouse bone marrow cells in microtiter liquid culture using the tetrazolium salt MTT, and its application to studies of myelopoiesis. Immunol Lett. 1988;19:261-8.
15. ® in malignant and normal endothelial cell lines. Folia Biol (Praha). 2007;53:7-12.
16. Nowis Dominika, Makowski Marcin, Stokłosa Tomasz, Legat Magdalena, Issat Tadeusz, Goła̧b Jakub. Direct tumor damage mechanisms of photodynamic therapy. Acta Biochim Pol. 2005;52:339-52.
17. Gibson SL, Murant RS, Hilf R. Photosensitizing effects of hematoporphyrin derivative and photofrin II on the plasma membrane enzymes 5′- nucleotidase, Na+K+-ATPase, and Mg2+-ATPase in R3230AC mammary adenocarcinomas. Cancer Res. 1988;48:3360-6.
18. Furuta M, Nozaki M, Kawashima M, Iimuro M, Okayama A, Fukushima M, et al. Monitoring mitochondrial metabolisms in irradiated human cancer cells with (99m)Tc-MIBI. Cancer Lett. 2004;212:105-11.
19. Casas A, Di Venosa G, Hasan T, Al Batlle. Mechanisms of resistance to photodynamic therapy. Curr Med Chem. 2011;18:2486-515.
20. Oberdanner CB, Kiesslich T, Krammer B, Plaetzer K. Glucose is required to maintain high ATP-levels for the energy-utilizing steps during PDT-induced apoptosis. Photochem Photobiol. 2002;76:695-703.
21. Cook JA, Mitchell JB. Viability measurements in mammalian cell systems. Anal Biochem. 1989;179:1-7.
22. Yamamoto J, Yamamoto S, Hirano T, Li S, Koide M, Kohno E, Namba H, et al. Monitoring of singlet oxygen is useful for predicting the photodynamic effects in the treatment for experimental glioma. Clin Cancer Res. 2006;12:7132-9.
23. Minn H, Lapela M, Klemi PJ, Grénman R, Leskinen S, Lindholm P, et al. Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer. J Nucl Med. 1997;38:1907-11.
24. Hendlisz A, Golfinopoulos V, Garcia C, Covas A, Emonts P, Ameye L, et al. Serial FDG-PET/CT for early outcome prediction in patients with metastatic colorectal cancer undergoing chemotherapy. Ann Oncol. 2012;23:1687-93.
25. Colavolpe C, Chinot O, Metellus P, Mancini J, Barrie M, Bequet-Boucard C, et al. FDG-PET predicts survival in recurrent high-grade gliomas treated with bevacizumab and irinotecan. Neuro Oncol. 2012;14:649-57.
26. Lisle JW, Eary JF, O'Sullivan J, Conrad EU. Risk assessment based on FDG-PET imaging in patients with synovial sarcoma. Clin Orthop Relat Res. 2009;467:1605-11.
27. Ueda S, Tsuda H, Asakawa H, Shigekawa T, Fukatsu K, Kondo N, et al. Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer. Jpn J Clin Oncol. 2008;38:250-8.
28. Buchbender C, Kuemmel S, Hoffmann O, Stahl AR, Kimmig R, Otterbach F, et al. FDG-PET/CT for the early prediction of histopathological complete response to neoadjuvant chemotherapy in breast cancer patients: initial results. Acta Radiol. 2012;53:628-36.
29. 18F-FDG PET/CT predict short-term outcome early in the course of chemoradiotherapy in advanced non-small cell lung cancer. Eur J Nucl Med Mol Imaging. 2011;38:1628-35.
30. Wang XS, Zhang YJ, Liu XL, Zhou ZR, Hu CS, Eisbruch A. The role of technetium-99m methoxyisobutyl isonitrile scintigraphy in predicting the therapeutic effect of chemotherapy against nasopharyngeal carcinoma. Cancer. 2011;117:2435-41.
31. Sohaib M, Wiqar MA, Ali MK, Hussain F. Umer-i-Farooq. A single (99m)Tc-MIBI study to predict response to neoadjuvant treatment in sarcoma patiens. Hell J Nucl Med. 2011;14:140-5.
32. Nagamachi S, Jinnouchi S, Ohnishi T, Nakahara H, Flores L 2nd, Tamura S, et al. The usefulness of Tc-99m MIBI for evaluating brain tumors: comparative study with Tl-201 and relation with P-glycoprotein. Clin Nucl Med. 1999;24:765-72.